Skip to Main Content

Paper Details

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Clin Cancer Res
33
2020
55 genes, Gene Expression, HGSOC, HGSOCs, High-grade Serous Ovarian Carcinoma, Ovarian Tumor, PrOTYPE, gene expression, high-grade serous tubo-ovarian cancer, minimal gene set, minimal gene set predictor, patient, tumor, tumor-infiltrating lymphocytes, tumors
Aged, Algorithms, Cystadenoma, Serous, Female, Gene Expression Regulation, Neoplastic, Humans, Lymphocytes, Tumor-Infiltrating, Middle Aged, Neoplasm Grading, Neoplasm Proteins, Neoplasm, Residual, Ovarian Neoplasms, Transcriptome
Author NameAffiliation
Aline TalhoukVancouver General Hospital, and University of British Columbia
Aline TalhoukUniversity of British Columbia
Joshy George
Joshy George
Chen WangMayo Clinic
Timothy BuddenUniversity of NSW Sydney
Timothy BuddenThe University of Manchester, CRUK Manchester Institute
Tuan Zea TanNational University of Singapore, Cancer Science Institute of Singapore, Center for Translational Medicine
Derek S ChiuVancouver General Hospital, and University of British Columbia
Stefan KommossTuebingen University Hospital
Stefan KommossTuebingen University Hospital
Huei San LeongPeter MacCallum Cancer Center
Stephanie ChenCedars-Sinai Medical Center, Center for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute
Maria P IntermaggioUniversity of NSW Sydney
Maria P IntermaggioUniversity of NSW Sydney
Cyril B GilksVancouver General Hospital, and University of British Columbia
Cyril B GilksUniversity of British Columbia
Tayyebeh M NazeranVancouver General Hospital, and University of British Columbia
Mila VolchekRoyal Women's Hospital
Wafaa ElatreNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
Rex C BentleyDuke University Hospital
Janine SenzVancouver General Hospital, and University of British Columbia
Janine SenzUniversity of British Columbia
Janine SenzVancouver General Hospital, and University of British Columbia
Janine SenzUniversity of British Columbia
Amy LumVancouver General Hospital, and University of British Columbia
Veronica ChowVancouver General Hospital, and University of British Columbia
Hanwei SudderuddinVancouver General Hospital, and University of British Columbia
Robertson MackenzieVancouver General Hospital, and University of British Columbia
Robertson MackenzieVancouver General Hospital, and University of British Columbia
Samuel C Y LeongVancouver General Hospital, and University of British Columbia
Geyi LiuVancouver General Hospital, and University of British Columbia
Dustin JohnsonVancouver General Hospital, and University of British Columbia
Billy ChenVancouver General Hospital, and University of British Columbia
Aocs GroupPeter MacCallum Cancer Center
Aocs GroupQIMR Berghofer Medical Research Institute
Aocs GroupThe Westmead Institute for Medical Research, The University of Sydney
Jennifer AlsopUniversity of Cambridge
Susana BanerjeeThe Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Sabine BehrensGerman Cancer Research Center (DKFZ)
Clara Bodelon
Alison BrandWestmead Hospital
Louise A Brinton
Louise A Brinton
Michael E CarneyUniversity of Hawaii, John A. Burns School of Medicine
Yoke-Eng ChiewThe Westmead Institute for Medical Research, The University of Sydney
Yoke-Eng ChiewWestmead Hospital
Kara L Cushing-HaugenFred Hutchinson Cancer Research Center
Cezary CybulskiPomeranian Medical University
Darren EnnisImperial College London, Division of Cancer and Ovarian Cancer Action Research Centre
  • 1 - 50

Datasets